27399912|t|Expression of WNT10A Gene in Oral Squamous Cell Carcinoma
27399912|a|Oral squamous cell carcinoma (OSCC) constitutes the most frequent malignant tumour of the oral cavity. Considering the significant roles the Wnt family plays in physiological and pathological events, this study aims to investigate WNT10A gene expression in OSCC. The cohort was composed of 59 specimens: 49 with OSCC and 10 controls. Total RNA from the samples was extracted, cDNA was synthesized and Real-time PCR analyses were performed, with β-ACTIN as internal control. The number of OSCC samples for the 4 TNM stages was: 5 (10.2%) stage I, 10 (20.4%) stage II, 9 (18.3%) stage III, and 25 (51.1%) stage IV. For Real-Time PCR analysis, significant difference was found between control samples and OSCC stage IV (p < 0.01). Higher levels of WNT10A expression was observed in OSCC stage IV suggesting a potential role in tumour progression.
27399912	0	10	Expression	T045	C0017262
27399912	14	25	WNT10A Gene	T028	C1422222
27399912	29	57	Oral Squamous Cell Carcinoma	T191	C0585362
27399912	58	86	Oral squamous cell carcinoma	T191	C0585362
27399912	88	92	OSCC	T191	C0585362
27399912	110	114	most	T081	C0205393
27399912	115	123	frequent	T079	C0332183
27399912	124	140	malignant tumour	T191	C0006826
27399912	148	159	oral cavity	T030	C0226896
27399912	177	188	significant	T078	C0750502
27399912	189	194	roles	T077	C1705810
27399912	199	209	Wnt family	T028	C0935995
27399912	219	232	physiological	T039	C1254359
27399912	237	249	pathological	T169	C1521733
27399912	250	256	events	T169	C0205245
27399912	263	268	study	T062	C2603343
27399912	277	288	investigate	T169	C1292732
27399912	289	300	WNT10A gene	T028	C1422222
27399912	301	311	expression	T045	C0017262
27399912	315	319	OSCC	T191	C0585362
27399912	325	331	cohort	T081	C0009247
27399912	351	360	specimens	T167	C0370003
27399912	370	374	OSCC	T191	C0585362
27399912	382	390	controls	T078	C1550040
27399912	392	397	Total	T080	C0439810
27399912	398	401	RNA	T114	C0035668
27399912	411	418	samples	T167	C0370003
27399912	423	432	extracted	T061	C0185115
27399912	434	438	cDNA	T114	C0006556
27399912	443	454	synthesized	T052	C1883254
27399912	459	481	Real-time PCR analyses	T059	C2732732
27399912	487	496	performed	T169	C0884358
27399912	503	510	β-ACTIN	T028	C1384510
27399912	514	530	internal control	T081	C0034925
27399912	536	542	number	T081	C0237753
27399912	546	550	OSCC	T191	C0585362
27399912	551	558	samples	T167	C0370003
27399912	569	579	TNM stages	T185	C1515169
27399912	595	602	stage I	T191	C0861585
27399912	615	623	stage II	T191	C0861598
27399912	635	644	stage III	T191	C0861611
27399912	661	669	stage IV	T191	C0861624
27399912	675	697	Real-Time PCR analysis	T059	C2732732
27399912	699	710	significant	T078	C0750502
27399912	711	721	difference	T080	C1705242
27399912	726	731	found	T033	C0150312
27399912	740	755	control samples	T078	C1550040
27399912	760	773	OSCC stage IV	T191	C0861624
27399912	786	792	Higher	T080	C0205250
27399912	793	799	levels	T080	C0441889
27399912	803	809	WNT10A	T028	C1422222
27399912	810	820	expression	T045	C0017262
27399912	825	833	observed	T169	C1441672
27399912	837	850	OSCC stage IV	T191	C0861624
27399912	851	861	suggesting	T078	C1705535
27399912	864	873	potential	T080	C3245505
27399912	874	878	role	T077	C1705810
27399912	882	900	tumour progression	T191	C0178874